GelStat Corp. (OTCMKTS:GSAC – Get Free Report) saw a significant increase in short interest in October. As of October 30th, there was short interest totaling 323,333 shares, an increase of 9,274.7% from the October 15th total of 3,449 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 9,993,765 shares, the days-to-cover ratio is presently 0.0 days.
GelStat Trading Up 50.0%
Shares of OTCMKTS GSAC opened at $0.00 on Wednesday. GelStat has a fifty-two week low of $0.00 and a fifty-two week high of $0.00.
GelStat Company Profile
GelStat Corporation is a specialty healthcare company associated with the development and marketing of over-the-counter products intended to address common health conditions. The company is best known for GelStat Migraine, a nonprescription product marketed for the temporary relief of migraine-related symptoms. Historically, GelStat’s product portfolio also included other consumer healthcare offerings, including products positioned for sleep support and relief from cold-related symptoms. The company’s approach focused on proprietary formulations and alternative delivery methods designed for direct consumer use rather than prescription-based treatment.
Further Reading
- Five stocks we like better than GelStat
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for GelStat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GelStat and related companies with MarketBeat.com's FREE daily email newsletter.
